Title |
From Culture to High-Throughput Sequencing and Beyond A Layperson’s Guide to the “Omics” and Diagnostic Potential of the Microbiome
|
---|---|
Published in |
Gastroenterology clinics of North America, March 2017
|
DOI | 10.1016/j.gtc.2016.09.003 |
Pubmed ID | |
Authors |
Paul W. O'Toole, Burkhardt Flemer |
Abstract |
Detailed knowledge of the community of organisms in the gut has become possible in recent years because of the development of culture-independent methods. Largely based on latest DNA sequencing platforms, it is now possible to establish the composition of the microbiota and the repertoire of biochemical functions it encodes. Variations in either or both of these parameters have been linked to intestinal and extraintestinal disease. This article summarizes how these methods are applied, with special reference to gastroenterology, and describes the achievements and future potential of microbiota analysis as a diagnostic tool. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 2 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 50 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 6 | 12% |
Student > Bachelor | 6 | 12% |
Student > Doctoral Student | 4 | 8% |
Student > Ph. D. Student | 4 | 8% |
Student > Master | 4 | 8% |
Other | 9 | 18% |
Unknown | 17 | 34% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 9 | 18% |
Agricultural and Biological Sciences | 7 | 14% |
Immunology and Microbiology | 5 | 10% |
Biochemistry, Genetics and Molecular Biology | 3 | 6% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 4% |
Other | 3 | 6% |
Unknown | 21 | 42% |